Cytel
Cambridge
About Cytel
Cytel is the provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have enabled biotech and pharmaceutical companies to navigate uncertainty, prove value and make confident, evidence-based decisions. Our experts deliver industry-leading software, data-driven analytics, real-world evidence and strategic consulting.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $2.0M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2021)
- Website: cytel.com
- Phone: 6176614405
Industries & Categories
Consulting, Software
Social Profiles
Canonical: https://fsome.com/organization/cytel-2236479 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.